Works matching AU Ailawadhi, Sikander

Results: 148
    1
    2
    3
    4
    5

    AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

    Published in:
    Cancers, 2023, v. 15, n. 2, p. 477, doi. 10.3390/cancers15020477
    By:
    • Ailawadhi, Sikander;
    • Parrondo, Ricardo D.;
    • Dutta, Navnita;
    • Han, Bing;
    • Ciccio, Gina;
    • Cherukuri, Yesesri;
    • Alegria, Victoria R.;
    • LaPlant, Betsy R.;
    • Roy, Vivek;
    • Sher, Taimur;
    • Edwards, Brett;
    • Lanier, Stephanie;
    • Manna, Alak;
    • Heslop, Keisha;
    • Caulfield, Thomas;
    • Maldosevic, Emir;
    • Storz, Peter;
    • Manochakian, Rami;
    • Asmann, Yan;
    • Chanan-Khan, Asher A.
    Publication type:
    Article
    6
    7
    8

    The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.

    Published in:
    Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01465-x
    By:
    • Rejeski, Kai;
    • Hansen, Doris K.;
    • Bansal, Radhika;
    • Sesques, Pierre;
    • Ailawadhi, Sikander;
    • Logue, Jennifer M.;
    • Bräunlein, Eva;
    • Cordas dos Santos, David M.;
    • Freeman, Ciara L.;
    • Alsina, Melissa;
    • Theurich, Sebastian;
    • Wang, Yucai;
    • Krackhardt, Angela M.;
    • Locke, Frederick L.;
    • Bachy, Emmanuel;
    • Jain, Michael D.;
    • Lin, Yi;
    • Subklewe, Marion
    Publication type:
    Article
    9
    10
    11
    12

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    13

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Article
    14

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    15

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    2023
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Letter
    16

    Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan-Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    17
    18

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    19
    20

    Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
    By:
    • Parrondo, Ricardo D.;
    • Rahman, Zaid Abdel;
    • Heckman, Michael G.;
    • Wieczorek, Mikolaj;
    • Jiang, Liuyan;
    • Alkhateeb, Hassan B.;
    • Litzow, Mark R.;
    • Greipp, Patricia;
    • Sher, Taimur;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Roy, Vivek;
    • Dispenzieri, Angela;
    • Kharfan-Dabaja, Mohamed A.;
    • Murthy, Hemant S.;
    • Ailawadhi, Sikander;
    • Foran, James M.
    Publication type:
    Article
    21
    22
    23
    24

    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0237-1
    By:
    • Kumar, Vivek;
    • Ailawadhi, Sikander;
    • Bojanini, Leyla;
    • Mehta, Aditya;
    • Biswas, Suman;
    • Sher, Taimur;
    • Roy, Vivek;
    • Vishnu, Prakash;
    • Marin-Acevedo, Julian;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Aulakh, Sonikpreet;
    • Iqbal, Madiha;
    • Manochakian, Rami;
    • Tan, Winston;
    • Chanan-Khan, Asher;
    • Ailawadhi, Meghna
    Publication type:
    Article
    25

    Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 12, p. 1789, doi. 10.1080/10428194.2024.2373331
    By:
    • Dimopoulos, Meletios A.;
    • Migkou, Magdalini;
    • Bhutani, Manisha;
    • Ailawadhi, Sikander;
    • Kalff, Anna;
    • Walcott, Farzana L.;
    • Pore, Nabendu;
    • Brown, Miranda;
    • Wang, Fujun;
    • Cheng, Lily I.;
    • Kagiampakis, Ioannis;
    • Williams, Marna;
    • Kinneer, Krista;
    • Wu, Yuling;
    • Jiang, Yu;
    • Kubiak, Robert J.;
    • Zonder, Jeffrey A.;
    • Larsen, Jeremy;
    • Sirdesai, Shreerang;
    • Yee, Andrew J.
    Publication type:
    Article
    26
    27
    28

    Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 308, doi. 10.1080/10428194.2020.1832669
    By:
    • Gunaratne, Madugodaralalage D. S. K.;
    • Sahakian, Alexander J.;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kapoor, Prashant;
    • Paulus, Aneel;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Novak, Anne J.;
    • Lacy, Martha Q.;
    • Kyle, Robert A.;
    • Go, Ronald S.;
    • Paludo, Jonas
    Publication type:
    Article
    29

    Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 2, p. 309, doi. 10.1080/10428194.2019.1672052
    By:
    • Siddiqi, Tanya;
    • Frankel, Paul;
    • Beumer, Jan H.;
    • Kiesel, Brian F.;
    • Christner, Susan;
    • Ruel, Chris;
    • Song, Joo Y.;
    • Chen, Robert;
    • Kelly, Kevin R.;
    • Ailawadhi, Sikander;
    • Kaesberg, Paul;
    • Popplewell, Leslie;
    • Puverel, Sandrine;
    • Piekarz, Richard;
    • Forman, Stephen J.;
    • Newman, Edward M.
    Publication type:
    Article
    30
    31

    Cardiac Myeloid Sarcoma: Review of Literature.

    Published in:
    Journal of Clinical & Diagnostic Research, 2017, v. 11, n. 3, p. 1, doi. 10.7860/JCDR/2017/23241.9499
    By:
    • GAUTAM, ARCHANA;
    • JALALI, GHAZAL KOOSHK;
    • SAHU, KAMAL KANT;
    • DEO, PRATEEK;
    • AILAWADHI, SIKANDER
    Publication type:
    Article
    32
    33

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article
    34

    Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan‐Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    35

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    36

    Measurement error and bias in real-world oncology endpoints when constructing external control arms.

    Published in:
    Frontiers in Drug Safety & Regulation, 2024, p. 1, doi. 10.3389/fdsfr.2024.1423493
    By:
    • Ackerman, Benjamin;
    • Gan, Ryan W.;
    • Meyer, Craig S.;
    • Wang, Jocelyn R.;
    • Zhang, Youyi;
    • Hayden, Jennifer;
    • Mahoney, Grace;
    • Lund, Jennifer L.;
    • Weberpals, Janick;
    • Schneeweiss, Sebastian;
    • Roose, James;
    • Siddique, Juned;
    • Nadeem, Omar;
    • Giri, Smith;
    • Stürmer, Til;
    • Ailawadhi, Sikander;
    • Batavia, Ashita S.;
    • Sarsour, Khaled
    Publication type:
    Article
    37
    38

    Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01177-6
    By:
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Omel, James;
    • Toomey, Kathleen;
    • Hardin, James W.;
    • Gasparetto, Cristina J.;
    • Jagannath, Sundar;
    • Rifkin, Robert M.;
    • Durie, Brian G. M.;
    • Narang, Mohit;
    • Terebelo, Howard R.;
    • Joshi, Prashant;
    • Jou, Ying-Ming;
    • Mouro, Jorge;
    • Yu, Edward;
    • Abonour, Rafat
    Publication type:
    Article
    39
    40
    41

    Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01081-z
    By:
    • Rees, Matthew J.;
    • Mammadzadeh, Aytaj;
    • Bolarinwa, Abiola;
    • Elhaj, Mohammed E.;
    • Bohra, Arwa;
    • Bansal, Radhika;
    • Ailawadhi, Sikander;
    • Parrondo, Ricardo;
    • Chhabra, Saurabh;
    • Khot, Amit;
    • Hayman, Suzanne;
    • Dispenzieri, Angela;
    • Buadi, Francis;
    • Dingli, David;
    • Warsame, Rahma;
    • Kapoor, Prashant;
    • Gertz, Morie A.;
    • Muchtar, Eli;
    • Kourelis, Taxiarchis;
    • Gonsalves, Wilson
    Publication type:
    Article
    42
    43

    Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 5, p. 337, doi. 10.1016/j.clml.2024.12.002
    By:
    • Ramasamy, Karthik;
    • Vij, Ravi;
    • Kuter, David;
    • Cella, David;
    • Durie, Brian G. M.;
    • Abonour, Rafat;
    • Rifkin, Robert M.;
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Cowan, Andrew J.;
    • Ho, Carrie;
    • Dhanasiri, Sujith;
    • Fish, Susan;
    • Yu, Edward;
    • Dhamane, Amol D.;
    • Jiaqi Fang;
    • Marshall, Thomas S.;
    • Samuel, Amir;
    • Liang Liu;
    • Katz, Jessica
    Publication type:
    Article
    44

    Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect® MM Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 58, doi. 10.1016/j.clml.2024.11.001
    By:
    • Terebelo, Howard R.;
    • Omel, James;
    • Wagner, Lynne I.;
    • Hardin, James W.;
    • Rifkin, Robert M.;
    • Ailawadhi, Sikander;
    • Durie, Brian G. M.;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Gasparetto, Cristina J.;
    • Joshi, Prashant;
    • Yu, Edward;
    • Flick, E. Dawn;
    • Ying-Ming Jou;
    • Lee, Hans C.;
    • Abonour, Rafat;
    • Jagannath, Sundar
    Publication type:
    Article
    45

    The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the Connect® MM Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e336, doi. 10.1016/j.clml.2024.05.021
    By:
    • Abonour, Rafat;
    • Lee, Hans C.;
    • Rifkin, Robert;
    • Ailawadhi, Sikander;
    • Omel, James;
    • Hardin, James W.;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Gasparetto, Cristina;
    • Wagner, Lynne I.;
    • Terebelo, Howard;
    • Mouro, Jorge;
    • Dhanasiri, Sujith;
    • Liu, Liang;
    • Yu, Edward;
    • Jagannath, Sundar
    Publication type:
    Article
    46
    47
    48

    Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 112, doi. 10.1016/j.clml.2022.11.008
    By:
    • Lee, Hans C.;
    • Ramasamy, Karthik;
    • Weisel, Katja;
    • Abonour, Rafat;
    • Hardin, James W.;
    • Rifkin, Robert M.;
    • Ailawadhi, Sikander;
    • Terebelo, Howard R.;
    • Durie, Brian G.M.;
    • Tang, Derek;
    • Joshi, Prashant;
    • Liu, Liang;
    • Jou, Ying-Ming;
    • Che, Min;
    • Hernandez, Gabriela;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Gasparetto, Cristina;
    • Wagner, Lynne I.;
    • Jagannath, Sundar
    Publication type:
    Article
    49

    Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 3, p. 149, doi. 10.1016/j.clml.2021.08.007
    By:
    • Gasparetto, Cristina;
    • Jagannath, Sundar;
    • Rifkin, Robert M.;
    • Durie, Brian G.M.;
    • Narang, Mohit;
    • Terebelo, Howard R.;
    • Toomey, Kathleen;
    • Hardin, James W.;
    • Wagner, Lynne;
    • Ailawadhi, Sikander;
    • Omel, James L.;
    • Srinivasan, Shankar;
    • Dhalla, Mazaher;
    • Catamero, Donna;
    • Kitali, Amani;
    • Agarwal, Amit;
    • Abonour, Rafat
    Publication type:
    Article
    50

    P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S109, doi. 10.1016/S2152-2650(21)02263-1
    By:
    • Wagner, Lynne;
    • Abonour, Rafat;
    • Ailawadhi, Sikander;
    • Durie, Brian G.M.;
    • Gasparetto, Cristina J.;
    • Hardin, James W.;
    • Lee, Hans;
    • Narang, Mohit;
    • Rifkin, Robert;
    • Terebelo, Howard;
    • Toomey, Kathleen;
    • Joshi, Prashant;
    • Agarwal, Amit;
    • Braverman, Julia;
    • Dhanda, Devender S.;
    • Mia He;
    • Jagannath, Sundar
    Publication type:
    Article